scispace - formally typeset
M

María Salud García-Gutiérrez

Researcher at Universidad Miguel Hernández de Elche

Publications -  63
Citations -  2499

María Salud García-Gutiérrez is an academic researcher from Universidad Miguel Hernández de Elche. The author has contributed to research in topics: Cannabinoid & Cannabinoid receptor. The author has an hindex of 25, co-authored 52 publications receiving 1799 citations. Previous affiliations of María Salud García-Gutiérrez include Spanish National Research Council & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.

Juan G. Zarruk, +10 more
- 01 Jan 2012 - 
TL;DR: The inhibitory effect of CB2R on the activation of different subpopulations of microglia/macrophages may account for the protective effect of the selectiveCB2R agonist JWH-133 after stroke.
Journal ArticleDOI

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

A. Ortega-Alvaro, +8 more
- 23 Mar 2011 - 
TL;DR: The results suggest that deletion of CB2r has a relation with schizophrenia-like behaviors and Pharmacological manipulation ofCB2r may merit further study as a potential therapeutic target for the treatment of schizophrenia-related disorders.
Journal ArticleDOI

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

María Salud García-Gutiérrez, +1 more
- 01 Jan 2011 - 
TL;DR: It is revealed that increased expression of CB2r significantly reduced anxiogenic-related behaviours, modified the response to stress and impaired the action of anxiolytic drugs.
Journal ArticleDOI

Chronic blockade of cannabinoid CB2 receptors induces anxiolytic‐like actions associated with alterations in GABAA receptors

María Salud García-Gutiérrez, +6 more
- 01 Feb 2012 - 
TL;DR: The aim of this study was to explore the effects of CB2 receptor agonist and antagonist in the regulation of anxiety‐like behaviours and to establish a causal relationship between CB2 receptors and anxiety-like behaviours.
Journal ArticleDOI

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Eva M. Marco, +6 more
- 05 Oct 2011 - 
TL;DR: The eCB system plays a critical role in psychiatry; however, detrimental consequences of manipulating this endogenous system cannot be underestimated over the potential and promising perspectives of its therapeutic manipulation.